UBS Group
VTAK icon

UBS Group’s Catheter Precision VTAK Stock Holding History

UBS Group’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$767 Sell
759
-779
-51% -$1.32K ﹤0.01% 9747
2025
Q4 		$2.81K Buy
+1,538
New +$3.54K ﹤0.01% 9217
2025
Q3 		– Sell
-3,934
Closed -$18.1K – 10979
2025
Q2 		$18.1K Buy
3,934
+3,881
+7,323% +$21K ﹤0.01% 8511
2025
Q1 		$344 Buy
53
+46
+657% +$348 ﹤0.01% 9814
2024
Q4 		$60 Sell
7
-144
-95% -$1.23K ﹤0.01% 9690
2024
Q3 		$1.13K Buy
151
+75
+99% +$2.41K ﹤0.01% 8709
2024
Q2 		$8.48K Buy
76
+21
+38% +$2.13K ﹤0.01% 7800
2024
Q1 		$5.04K Sell
55
-1
-2% -$89 ﹤0.01% 7565
2023
Q4 		$4.32K Buy
+56
New +$4.57K ﹤0.01% 7876
2023
Q3 		– Sell
-16
Closed -$2.76K – 10007
2023
Q2 		$2.76K Buy
+16
New +$3.69K ﹤0.01% 7701
2023
Q1 		– Sell
-27
Closed -$30.5K – 10447
2022
Q4 		$30.5K Buy
+27
New +$22.4K ﹤0.01% 7226
2022
Q3 		– Sell
-4
Closed -$12K – 10979
2022
Q2 		$12K Sell
4
-3
-43% -$9.27K ﹤0.01% 7685
2022
Q1 		$27K Buy
+7
New +$47.6K ﹤0.01% 7111
2021
Q4 		– Hold
0
– -$8K – 10752
2021
Q3 		– Hold
0
– – – 8232
2021
Q1 		– Hold
0
– -$3K – 9529
2020
Q4 		– Sell
-1
Closed -$59.5K – 8021
2020
Q3 		$53K Buy
+1
New +$79.6K ﹤0.01% 5608
2020
Q2 		– Hold
0
– – – 7392
2020
Q1 		– Hold
0
– – – 7022
2019
Q4 		– Hold
0
– – – 7983
2019
Q3 		– Hold
0
– – – 7119
2018
Q4 		– Hold
0
– -$28K – 8328
2018
Q3 		– Hold
0
– – – 6592

Other funds holding VTAK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.42B AUM
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

UBS Group's VTAK Position: Q1 2026 in Review

UBS Group reduced its Catheter Precision (VTAK) stake by 51% in Q1 2026, selling an estimated $1.32K and leaving 759 shares worth $767. The position accounts for ﹤0.01% of the portfolio, ranked #9747.

UBS Group first reported a position in VTAK in Q3 2020 and has held it in 14 quarters since. The position peaked at $53K in Q3 2020. 12 funds tracked by Wall St. Rank hold VTAK as of Q1 2026.

  • UBS Group held 759 shares of Catheter Precision worth $767 as of Q1 2026.
  • UBS Group sold 779 Catheter Precision shares in Q1 2026, an estimated $1.32K.
  • Catheter Precision made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9747 holding.
  • UBS Group first reported a position in Catheter Precision in Q3 2020 and has held it in 14 quarters since.
  • UBS Group's Catheter Precision position peaked at $53K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.